No-Cost, No-Obligation Nevada Risperdal Lawsuit Review

Information about Nevada Risperdal Lawsuits from Lawyers Handling Nevada Risperdal Boys Breast Growth Lawsuits

Nevada Risperdal Male Breasts Lawsuits

Nevada Risperdal Lawsuits Filed for Boys Breast Development - Attorneys Handling Risperdal Male Breasts Lawsuits in Nevada Offer No-Cost, No-Obligation Risperdal Gynecomastia Case Review

Risperdal Male Breasts

Risperdal (risperidone), an antipsychotic drug approved for use in children and adults with schizophrenia, Bipolar I Disorder, and autism, has been found to cause gynecomastia, or breast development in boys. Risperdal causes male breast development by elevating prolactin levels in the body, which results in a hormone imbalance. While gynecomastia has few physical health implications, Risperdal breast growth in boys can result in staggering emotional trauma and social derision. The first Risperdal male breast lawsuit, which settled in 2012 on its first day in court, asserted that the cosmetic and pharmaceutical giant Johnson & Johnson understated the impact of excess prolactin and downplayed the correlation between Risperdal and male breast development. Teenage boys and young men who suffer from Risperdal gynecomastia may require mastectomy surgery and years of therapy or psychiatric treatment. Risperdal has been the subject of numerous state and federal lawsuits, including a record $2.2 billion settlement with the U.S. Department of Justice in 2013 over fraudulent advertising, the payment of illegal kickbacks for prescribing Risperdal for off-label uses, and the understatement of Risperdal side effects. At its height in 2007, Risperdal was among Johnson & Johnson’s best-selling drugs, yielding annual sales of $4.5 billion.

Numerous studies have revealed that, as a result of elevating prolactin levels, Risperdal causes breast development in boys. Critics say the company downplays the social and emotional effect of male breast development, pointing to the significant mental anguish and trauma that results when teenage boys grow breasts. In a Wall Street Journal piece, Dr. P. Murali Doraiswamy, the Duke psychiatrist who co-authored an FDA study on prolactin and antipsychotics, noted that Risperdal has the highest risk of male breast development of any drug in its class, accounting for 70% of male breasts in the study. He said the hormone imbalance that leads to Risperdal gynecomastia “can’t be considered harmless” as has been suggested by Janssen representatives. No one yet knows how many Risperdal boys breast development claims will surface, yet hundreds of Risperdal lawsuits have already been filed in Nevada. Plaintiffs in a Nevada Risperdal male breast lawsuit may seek damages for surgical procedures, medical expenses, mental anguish, and other associated losses.

Risperdal gynecomastia lawsuits are one among many types of product liability suits faced by Johnson & Johnson at present. An astounding number of products have been under scrutiny for serious safety risks, and the company has issued a seemingly endless string of product recalls. A vast array of Tylenol products was recalled in 2012 and 2013, related to severe Tylenol liver damage and other health problems. The Johnson & Johnson subsidiary DePuy recalled hip replacement parts and a record settlement was reached in 2013 after tens of thousands of metal parts failed, requiring repeat hip replacement surgery in throngs of patients. And a federal jury confirmed a link between Johnson’s baby powder and ovarian cancer in late 2013. Despite the Rispderal male breast settlements and many other product liability lawsuits, the company’s profits continue to climb. Johnson & Johnson reported more than $71 billion in sales during 2013, representing a 6.1% growth rate over 2012’s earnings of over $67 billion.

Nevada Risperdal lawyers believe that boys and men, and the family members of boys and men, who developed breasts while taking Risperdal may be entitled to compensation for damages, harm, and loss they suffered as a result of gynecomastia from Risperdal. The degree of emotional damage that can be caused by Risperdal boys breast growth cannot be overstated, and males who have suffered from Risperdal gynecomastia have the right to explore their legal options. Each Nevada Risperdal male breast lawsuit that is filed against the company may serve to increase Johnson & Johnson’s accountability for consumer safety in the future. The Nevada Risperdal Gynecomastia Lawsuit Center offers comprehensive information on Rispderal gynecomastia risks, side effects and warnings, as well as information about how to contact a Risperdal lawyer in Nevada or file a Nevada Risperdal lawsuit for boys breast growth.

Risperdal Risks and Side Effects

Risperdal Risks and Side EffectsRisperdal affects the body’s balance of key hormones by increasing the amount of prolactin, a natural hormone related to lactation. In studies comparing hormone levels in users of various antipsychotic drugs, Risperdal has been found to cause the highest level of prolactin and the greatest risk for breast development in boys and men. Scientists and medical experts say the Risperdal gynecomastia risk and the side effects from male breast growth are more significant than the pharmaceutical company Johnson & Johnson admits. This page provides information about Risperdal and male breasts, including data about the emotional trauma caused by gynecomastia and the scientific explanation for boys breast development.

Risperdal Male Breasts Warning Information for Nevada

Risperdal Boys Breast Development Warning for Residents of Nevada

Pre-market research conducted by Johnson & Johnson subsidiary Janssen revealed Risperdal’s tendency to cause gynecomastia. Yet medical experts assert that the gynecomastia warning on the Risperdal label understates the risk and fails to adequately issue a warning for breast development in males taking Risperdal. This page discusses the contents of the current Risperdal warning label, a need for a greater Risperdal breast development warning for boys and men, and efforts to solicit a stronger Risperdal male breast growth warning from the FDA.

Risperdal Male Breasts Lawsuit

Nevada Risperdal Male Breast Lawsuits

The first Risperdal gynecomastia lawsuit was filed by a young adult who developed breasts while taking Risperdal between the ages of 9 and 14. The young man required surgery to remove the breast tissue, and suffered from a great degree of social and emotional trauma. This and subsequent Risperdal lawsuits have asserted that Janssen and its parent company Johnson & Johnson failed to adequately warn consumers that boys could grow breasts while taking Risperdal. If you or a loved one developed male breasts while taking Risperdal in Nevada, you may be entitled to compensation through a Nevada Risperdal gynecomastia lawsuit.

Risperdal Male Breasts Lawyers FAQ

Risperdal Boys Breasts Lawsuit FAQs for Residents of Nevada

The Nevada Risperdal Breast Growth in Boys Lawsuit FAQs page provides answers to the questions most often asked of our attorneys handling Risperdal gynecomastia lawsuits in Nevada. Contained within this page is information about the research behind the Risperdal male breast link, who can file a Nevada Risperdal boys breast lawsuit, and tips for how to file a Risperdal gynecomastia claim in Nevada.
Risperdal Male Breasts Lawyer in Nevada

Risperdal Breast Growth Lawyers in Nevada

This page describes the legal services provided by our Nevada Risperdal male breast growth lawyer team. Because our firm works on a contingency basis, there is never any fee for Risperdal gynecomastia lawyer services in Nevada unless we collect for you. Risperdal boys breast lawyers are providing free case reviews for persons in Nevada who believe they may have grounds for a Risperdal claim.